Life-saving hepatitis C drug approved, but cost is high

Following approvals in the US and Europe this month of a new drug to treat hepatitis C, activists are pushing for the medication to be made available in poor countries, a development reminiscent of the activism that forced down HIV/AIDS drug prices a decade ago in Brazil, South Africa and Thailand.

http://gantdaily.com/2013/12/23/life-saving-hepatitis-c-drug-approved-but-cost-is-high/?#038;#038;